Vaccinology in sub-Saharan Africa.
Jennifer MoïsiShabir Ahmed MadhiHelen ReesPublished in: BMJ global health (2019)
We undertook a landscape analysis of vaccinology research and training in sub-Saharan Africa in order to identify key gaps and opportunities for capacity development in the field. We conducted interviews with regional and global immunisation experts, reviewed university and research centre websites, searched the scientific literature and analysed donor databases as part of our mapping exercise. We found that (1) few vaccinology training programmes are available in the region; (2) vaccinology research sites are numerous but unevenly distributed across countries and subregions and of widely varying capacity; (3) donor funding favours HIV, tuberculosis and malaria vaccine development over other high-burden diseases; (4) lack of vaccine design, manufacturing and regulatory capacity slows the progress of new vaccines through the research and development pipeline and (5) vaccine implementation research garners limited support. Regional efforts to strengthen African vaccinology expertise should develop advanced vaccinology training programmes, support clinical trial and implementation research sites in geographic areas with limited capacity and conduct multidisciplinary research to help design, license and roll out new vaccines.
Keyphrases
- clinical trial
- quality improvement
- primary care
- healthcare
- systematic review
- virtual reality
- hiv aids
- human immunodeficiency virus
- hiv testing
- high resolution
- physical activity
- transcription factor
- big data
- randomized controlled trial
- machine learning
- mass spectrometry
- study protocol
- men who have sex with men
- neural network
- artificial intelligence
- pulmonary tuberculosis
- adverse drug
- electronic health record